Riskpilot← Back to searchSign inGet full accessBoboDoc AB
ABActiveOrg 5569380180Stensbergsgatan 11Medical specialists activities · NACE 8622Est. 20132 employees
Revenue 2025
SEK 4,3M
0% vs 2024
EBITDA margin
42.2%
+4% vs 2024
Equity ratio
83.7%
Financial strength
Net profit 2025
SEK 1,2M
-2% vs 2024
| Revenue | SEK 4,3M | +0% |
| EBITDA | SEK 1,8M | +4% |
| Net profit | SEK 1,2M | -2% |
| Total assets | SEK 2,4M | -17% |
| Equity | SEK 2M | -14% |
| Employees | 2 | — |
Legal name
BoboDoc AB
Org number
5569380180
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
24 juli 2013
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är öppenvårds specialistläkarmottagning inom internmedicin samt kardiologi, uthyrning av legitimerade läkare, konsultverksamhet, undervisning, forskning inom sjukvård, handel med värdepapper, fast egendom och därmed förenlig verksamhet.
Address
Stensbergsgatan 11
Phone
+4673706989
Email
karim.abdulhadi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 448 | 2 620 | 3 831 | 4 277 | 4 284 |
| Staff expenses | — | −1 170 | — | −1 886 | — |
| EBITDA | 409 | 931 | 1 474 | 1 737 | 1 809 |
| Depreciation & amort. | −30 | −65 | −128 | −207 | −328 |
| EBIT | 379 | 867 | 1 346 | 1 530 | 1 481 |
| Net financials | — | −24 | −1 | −8 | 3 |
| Profit before tax | 380 | 843 | 1 346 | 1 522 | 1 485 |
| Tax | −69 | −174 | −278 | −318 | −308 |
| Net profit | 311 | 669 | 1 068 | 1 204 | 1 177 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 575 | 1 813 | 2 149 | 2 911 | 2 405 |
| Equity | 395 | 1 064 | 1 632 | 2 336 | 2 013 |
| Long-term debt | 0 | — | 0 | — | 0 |
| Short-term debt | 180 | 749 | 517 | 575 | 392 |
| Total debt | 180 | 749 | 517 | 575 | 392 |
EBITDA margin
42.2%
This company
15.8%
Market median
+167% vs market
20212025
Equity ratio
83.7%
This company
38.2%
Market median
+119% vs market
20212025
Return on equity
58.5%
This company
18.4%
Market median
+218% vs market
20212025
Net profit margin
27.5%
This company
8.1%
Market median
+240% vs market
20212025
Asset turnover
1.78×
This company
1.12×
Market median
+59% vs market
20212025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SJ Chief Auditor | Chief Auditor | 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
NN | Deputy Board Member | 2021 |
| Former (1) | ||
| Deputy Board Member | 2021 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BoboDoc AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sebastian Johan Lennevi | Chief Auditor | 0 companies |
| Handrin Karim Abdulhadi | Board of Directors | 0 companies |
| Christina Anna Elisabeth Karlsson | Deputy Board Member | 0 companies |
| Nora Ny | Deputy Board Member | 0 companies |